Mutation in ras proto-oncogenes and malignancy.
Marshall
C J
CJ
Institute of Cancer Research, Chester Beaty Laboratories, London, U.K.
D002273:Carcinogens / Q000633:toxicity; D002471:Cell Transformation, Neoplastic / Q000378:metabolism; D004789:Enzyme Activation; D005786:Gene Expression Regulation; D011905:Genes, ras / Q000187:drug effects; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000235:genetics; D009154:Mutation; D009369:Neoplasms / Q000235:genetics*; D015689:Oncogene Protein p21(ras); D009856:Oncogene Proteins, Viral / Q000378:metabolism / Q000502:physiology; D011493:Protein Kinase C / Q000378:metabolism; D015398:Signal Transduction
D002273:Carcinogens; D009856:Oncogene Proteins, Viral; D011493:Protein Kinase C; D015689:Oncogene Protein p21(ras)